SCHEMBL3407639

SCHEMBL3407639

CC(C)CC(N)c1ccccc1N1CCCCC1.O=C(OC(C(=O)O)(C(=O)c1ccccc1)C(O)C(=O)O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 16/20 0.42
▸ CYP3A4 P08684 2/20 0.39
▸ ABCC8 Q09428 2/20 0.37
▸ SLC22A1 O15245 1/20 0.37
▸ ABCC3 O15438 1/20 0.37
▸ ABCC4 O15439 1/20 0.37
▸ NR1I2 O75469 1/20 0.37
▸ ABCB11 O95342 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ADORA3 P0DMS8 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ PTGS2 P35354 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ NR1I3 Q14994 1/20 0.37
▸ ABCC2 Q92887 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ CACNA1B Q00975 1/20 0.36
▸ KCNQ2 O43526 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3014397 0.95 MC4R (0.40) MC4RCYP3A4ABCC8LMNA
SCHEMBL3408856 0.81 MC4R (0.48) MC4RCYP3A4ABCC8SLC22A1ABCC3
SCHEMBL2344486 0.81 MC4R (0.48) MC4RCYP3A4ABCC8SLC22A1ABCC3
SCHEMBL3014389 0.76 MC4R (0.45) MC4RCYP3A4ABCC8LMNA
Hydroxyamine SCHEMBL11026958 0.75 TSHR (0.41) LMNAMAPK1
SCHEMBL17871701 0.75 MC4R (0.54) MC4RCYP3A4MAPK1KCNQ2
SCHEMBL223031 0.75 TSHR (0.43) LMNAMAPK1
SCHEMBL1964089 0.75 MC4R (0.54) MC4RCYP3A4MAPK1KCNQ2
SCHEMBL442668 0.75 MC4R (0.54) MC4RCYP3A4MAPK1KCNQ2
SCHEMBL2904556 0.75 TSHR (0.43) LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177221-A1 Process for the preparation of substantially optically pure Repaglinide and precursors thereof Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2010-04-21 — — EP disclosed
Send feedback